Atlantis Symbicort
NCT00646594 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1200
Last updated 2009-03-27
Summary
The purpose of this study is to determine whether Symbicort compared with Advair, will be more effective in controlling asthma in adults and adolescents.
Conditions
Interventions
- DRUG
-
budesonide/formoterol (Symbicort)
- DRUG
-
fluticasone/salmeterol (Advair)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Mitchell Golmand, MD · AstraZeneca
-
Catherine Bonuccelli · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-11-30
- Completion
- 2005-01-31
More Related Trials
-
Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler
NCT00658255 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Efficacy of Symbicort® SMART.
NCT00839800 ·Status: COMPLETED ·Phase: PHASE3
-
SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults
NCT00259792 ·Status: COMPLETED ·Phase: PHASE3
-
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
NCT01360021 ·Status: COMPLETED ·Phase: PHASE3
-
SHARE - Symbicort and Health Economics in a Real Life Evaluation
NCT00259766 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
NCT02091986 ·Status: COMPLETED ·Phase: PHASE3
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00385593 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT
NCT00646321 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Onset of Action 1
NCT00646620 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®
NCT00244608 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5
NCT00652002 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics
NCT02496715 ·Status: WITHDRAWN ·Phase: PHASE3
-
SIM0718 Treatment of Asthma Clinical Study
NCT06488755 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg
NCT00242775 ·Status: COMPLETED ·Phase: PHASE3
-
Study In Asthma Control
NCT00273026 ·Status: TERMINATED ·Phase: PHASE4
-
Long-Term Safety of Symbicort in Asthmatic Children - SAPLING
NCT00646529 ·Status: COMPLETED ·Phase: PHASE3
-
A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®
NCT00884689 ·Status: COMPLETED
-
Symbicort in Asthmatic Children - SEEDLING
NCT00651547 ·Status: COMPLETED ·Phase: PHASE3
-
Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans
NCT00702325 ·Status: COMPLETED ·Phase: PHASE4
-
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
NCT00235911 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation
NCT01232335 ·Status: COMPLETED
-
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
NCT01232348 ·Status: COMPLETED